ProPhase Labs, Inc. manufactures, markets, and distributes a range of homeopathic and health care products to general public in the United States. The company also engages in the research and development of over-the-counter drugs and natural base health products with supplements, personal care, and cosmeceutical products. It offers Cold-EEZE cold remedy zinc gluconate lozenges that reduces the duration and severity of symptoms of the common cold; and non-lozenge forms of its proprietary zinc gluconate formulation, including Cold-EEZE cold remedy QuickMelts, Cold-EEZE Gummies, and Cold-EEZE cold remedy oral spray. The company's Cold-EEZE cold remedy QuickMelts product line consists of Cold-EEZE Daytime/Nighttime QuickMelts, Cold-EEZE Plus Immune Support + Energy QuickMelts, and Cold-EEZE Plus Multi-Symptom QuickMelts. It also offers Cold-EEZE Multi-Symptom Relief for cold and flu lozenge; Cold-EEZE Daytime and Nighttime Multi-Symptom Relief in liquid form for adults and children; and Cold-EEZE Natural Allergy Relief caplets for indoor and outdoor allergies, as well as Cold-EEZE Nighttime Multi-Symptom Relief for Cold and Flu QuickMelts. In addition, the company provides organic cough drops and a vitamin C supplement; and contract manufacturing services of cough drop, dietary supplements, and other OTC cold remedy products for third parties, as well as produces private label lozenge products for retail customers. It markets its products through national chain, regional, specialty, and local retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania.
http://www.priceseries.com/trade/PRPH-ProPhase-Labs-Inc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2021010420210119.html
Subscribe by Email
Follow Updates Articles from This Blog via Email
No Comments